Trump has also promised to lower drug prices, but his proposed tariffs could result in higher drug prices and slow innovation in developing new therapies. In other healthcare news, biotech venture fund Jupiter Bioventures and Initiate Ventures have closed initial financing rounds, and the FDA has approved new treatments for leukemia and a genetic disorder affecting neural transmission. The Forbes CIO Next list has recognized several healthcare industry executives for their technological deployments.
Key takeaways:
- President-elect Trump plans to appoint Robert F. Kennedy, Jr. for Secretary of Health and Human Services and Mehmet Oz for administrator of the Centers for Medicare and Medicaid Services.
- Biopharma stocks have been underperforming since the election due to uncertainty about healthcare policy.
- Trump's proposed tariffs could result in higher drug prices for consumers and a slowdown of innovation in developing new therapies.
- The Forbes CIO Next list recognizes executives making key technological deployments in their companies, including several in the healthcare industry.